Milestone Pharmaceuticals Inc (MIST)

Don’t underestimate mist at these levels you will be banking tons 

Must going to 5 + EOS , still loading while dumping nwbo 

Started position , blowing out third round of NWBO  buying mist 

Milestone Pharmaceuticals shares plunge after CARDAMYST revenue misses expectations (MIST)May 13, 2026 9:34 AM
IH Market News Shares of Milestone Pharmaceuticals (NASDAQ:MIST) dropped nearly 16% in premarket trading on Wednesday after the company reported first-quarter results that fell well below analyst revenue expectations following the initial launch of CARDAMYST.The stock declined 15.92% after the earnings release. Revenue falls far short of forecasts Milestone reported a quarterly loss of -$0.20 per share for the period ended March 31, 2026, compared with analyst expectations for earnings of $0.23 per share.Revenue totaled $238 thousand, significantly below the analyst consensus estimate of $56.34 million.The company generated no revenue in the same quarter last year. CARDAMYST launch underway Milestone began the commercial rollout of CARDAMYST nasal spray for paroxysmal supraventricular tachycardia (PSVT) in mid-February 2026.According to the company, approximately 600 prescriptions had been filled for around 560 patients through April.“We’re excited to report on our first quarter of sales for CARDAMYST for paroxysmal supraventricular tachycardia, or PSVT,” said Joseph Oliveto, president and chief executive officer of Milestone Pharmaceuticals.“Healthcare professionals’ initial reaction to the product is positive and we are very encouraged by the early breadth of unique prescribers writing for their patients.” Insurance coverage expands The company said it secured national formulary coverage from Express Scripts in March.Milestone added that more than 25% of commercially insured individuals in the United States now have coverage access for CARDAMYST.Approximately 400 unique prescribers have already initiated treatment for patients using the therapy. Commercial launch costs weigh on results Net loss for the quarter widened to $26.1 million from $20.8 million in the prior-year period.Commercial expenses rose to $15.8 million from $10.4 million year-on-year, primarily due to costs associated with the launch of CARDAMYST. Cash position supports operations into 2027 Milestone reported cash, cash equivalents and short-term investments totaling $184.2 million as of March 31, 2026.The company said it expects existing resources to fund operations into the second half of 2027. Phase 3 programme advances Milestone has also initiated a Phase 3 registrational programme evaluating etripamil for atrial fibrillation with rapid ventricular rate.Patient enrollment in the study is expected to begin during the second half of 2026.Milestone Pharmaceuticals stock price Original: Milestone Pharmaceuticals shares plunge after CARDAMYST revenue misses expectations (MIST)

mist.....................https://stockcharts.com/sc3/ui/?s=MIST&p=w&b=5&g=0&id=p86431144783

MIST blowing up on FDA my first FDA approval catch before the news. Always liked this bio

APPROVED. Conference Call Monday morning
$MIST PR link:
investors.milestonepharma.c...

MIST bio beast ready to rumble into weekly breakout

Nice recovery

What junk, what a bunch of manipulation!

MEH

Over 2.50

Over $2

MIST under $2

MIST under $3

MIST under $2

MIST under $2

MIST under $2

MIST under $2

KIND 10Q 2/27

NUVB was on my GOLDEN CROSS scanner 11days ago,thought it was overbought,ohhh boy was i wrong

NUVB under $2

VERO is the most promising on my scanner,when the offering is closed it could do really well,global sales could drive the greed buying

i just made up a screener on finviz for new lows,and some other parameters,i will do some tweaking over next few days after doing back testing,BRSH is #1 right now,will see how that does,thanks again bro!!!

I won’t check the new 52 week lows and new 52 week highs lists from Barchart until later in the day
Barchart doesn’t include stocks priced below 25 cents

i noticed you posting those,thats a really good idea,lower risk and quite often before a big run is a big drop,usually when a dilution/debt nears end they just dump remaining shares (sometimes 200k-500K) and once dilution/debt is done the ticker moves up like crazy(even with low vol.) thanks for taking the time to post those and for letting me know about tickers i have posted on in past.

If you view Friday’s chart you should view the low of the day at the close of trade
There is a recurring pattern of stocks at a day’s low, especially a 12 month low bouncing higher the following day

charting up well,nice one bro!!!

No 2 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

MIST under $2

MIST new 52 week low

MIST So Sunday I said MIST should rise this week, due to a lot of inside buying that came out Friday. Let's see how it has done:

Friday's close was $5.11
Monday it reached 5.60
A +9.6% stretch!

And today it has reached 5.79
Increasing the stretch to +13.3%

Those who played are planning their weekend away
Those who did not are scanning the supermarket circulars

LOL

No opps here, But thanks anyway.
Go $MIST

Can u say opps. Take profits. Its pharma. You could be below 1.00 soon

* * $MIST Video Chart 07-24-2020 * *

Link to Video - click here to watch the technical chart video

fitzkarz Friday, 05/01/20 02:07:21 PM
Re: swingingRichard post# 16 0
Post # of 38

IMO $MIST should be, And will be between $8 & $12 short term

No kidding from my original shares @ 1.95 averaging up.
I done great. Yes MISTified!

10.37 MISTafied

* * $MIST Video Chart 07-23-2020 * *

Link to Video - click here to watch the technical chart video

$MIST Spaceship!!! HALTED at HOD

"We are pleased with the outcome of our recent interactions with the FDA, as they outline an efficient path to registration for etripamil which eliminates the need to start a new Phase 3 study," said Joseph Oliveto, President and Chief Executive Officer of Milestone Pharmaceuticals.

That has been my sentiment all morning.....

$MIST, Fricken awesome!

This is useless. Investors want a way to hedge their bets. These little post mortem videos are a waste. So much for front running.

* * $MIST Video Chart 06-09-2020 * *

Link to Video - click here to watch the technical chart video

I stand corrected . . .

$Mist, Awesome
Day's High
7.14
Day's Low
4.45

$MIST slow and steady!

No, The bottom is still moving up.

$MIST slow and steady back towards $20.

$8 to $12 short term. IMO

Looking like this ran out of steam. Honestly, I'm a little surprised. Maybe there will be another run. It is trading below cash value, right?